Picture of Oriola Oyj logo

OKDBV Oriola Oyj Share Price

0.000.00%
fi flag iconLast trade - 00:00
HealthcareBalancedSmall CapNeutral

Momentum

Relative Strength (%)
1m+4.91%
3m-6.97%
6m-2.09%
1yr-32.29%
Volume Change (%)
10d/3m-50.59%
Price vs... (%)
52w High-29.54%
50d MA-2.39%
200d MA+0.45%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)15.15
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)6.63%
Valuation (ttm)IndustryMarket
Price to Book Value1.1
Price to Tang. Book1.57
Price to Free Cashflow31.44
Price to Sales0.13
EV to EBITDA18.11

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-2.71%
Return on Equity-10.43%
Operating Margin-0.35%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue€m1,721.31,800.81,452.21,515.51,493.81,515.251,564.25-0.76%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-48.83+0.36+3.91-5.82n/an/a+60.34n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Oriola Oyj EPS forecast chart

Profile Summary

Oriola Oyj, formerly known as Oriola-KD Corporation Oyj, is a Finland-based company active in the pharmaceutical sector. The Company is engaged in the retail and wholesale of pharmaceuticals, acting as a channel between pharmaceutical manufacturers and consumers, primarily in Finland and Sweden. The Company's reporting segments are Consumer, Services, and Healthcare. Through its own pharmacies, the Company provides consumers with not only medicines and pharmaceutical advice but also a selection of healthcare consumer products and customer service. The Company is active through a number of subsidiaries located throughout Europe, including PharmaService OY, Oriola AB, Oriola Oyj, Farenta Oy, Kronans Droghandel Apotek AB and Svensk dos AB.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
July 1st, 2006
Public Since
July 3rd, 2006
No. of Employees
801
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
fi flag iconOMX Nordic Exchange - Helsinki
Shares in Issue
181,398,787

OKDBV Share Price Performance

Upcoming Events for OKDBV

Q1 2024 Oriola Oyj Earnings Release

Q2 2024 Oriola Oyj Earnings Release

Similar to OKDBV

Picture of Orion Oyj logo

Orion Oyj

fi flag iconOMX Nordic Exchange - Helsinki

FAQ